Dexmedetomidine for sedation of patients in the ICU or PICU: review of clinical effectiveness and safety
CADTH
Record ID 32014000841
English
Authors' recommendations:
Four meta-analyses, one systematic review, and five randomized-controlled trials were included in this review. The available evidence indicates the use of dexmedetomidine was associated with decreased ICU stay and decreased time on mechanical ventilation. However, it was associated with higher rates of bradycardia than comparators.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.cadth.ca/media/pdf/htis/feb-2014/RC0512%20Dexmedetomidine%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Hypnotics and Sedatives
- Intensive Care Units
- Child
- Adult
- Intensive Care Units, Pediatric
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.